CW June 2000

category image Volume 9
Issue Number 6
June 2000
ISSN 10593802

Single-Agent Herceptin in Metastatic Breast Cancer

Herceptin (trastuzumab) is showing promise as a single agent against metastatic breast cancer, especially in patients who are overexpressors of the human epidermal growth factor receptor 2 (HER2) protein.
Go to Previous Page
Go to Next Page

Source & Additional Reading

Reports from ASCO Meeting.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW June 2000

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login